Wells Fargo’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $515K | Buy |
34,409
+4,374
| +15% | +$65.5K | ﹤0.01% | 3769 |
|
|
2025
Q1 | $485K | Buy |
30,035
+5,317
| +22% | +$85.8K | ﹤0.01% | 3701 |
|
|
2024
Q4 | $575K | Buy |
24,718
+6,908
| +39% | +$161K | ﹤0.01% | 3623 |
|
|
2024
Q3 | $524K | Buy |
17,810
+635
| +4% | +$18.7K | ﹤0.01% | 3598 |
|
|
2024
Q2 | $404K | Buy |
17,175
+14,933
| +666% | +$351K | ﹤0.01% | 3706 |
|
|
2024
Q1 | $85K | Buy |
2,242
+2,219
| +9,648% | +$84.2K | ﹤0.01% | 4608 |
|
|
2023
Q4 | $495 | Buy |
23
+1
| +5% | +$22 | ﹤0.01% | 5941 |
|
|
2023
Q3 | $270 | Sell |
22
-328
| -94% | -$4.03K | ﹤0.01% | 6135 |
|
|
2023
Q2 | $3.94K | Buy |
350
+21
| +6% | +$236 | ﹤0.01% | 5803 |
|
|
2023
Q1 | $2.39K | Buy |
329
+227
| +223% | +$1.65K | ﹤0.01% | 5878 |
|
|
2022
Q4 | $1.15K | Buy |
102
+1
| +1% | +$11 | ﹤0.01% | 5815 |
|
|
2022
Q3 | $1K | Buy |
101
+3
| +3% | +$30 | ﹤0.01% | 6135 |
|
|
2022
Q2 | $1K | Sell |
98
-183
| -65% | -$1.87K | ﹤0.01% | 6306 |
|
|
2022
Q1 | $16K | Sell |
281
-572
| -67% | -$32.6K | ﹤0.01% | 5761 |
|
|
2021
Q4 | $101K | Buy |
853
+765
| +869% | +$90.6K | ﹤0.01% | 5234 |
|
|
2021
Q3 | $18K | Hold |
88
| – | – | ﹤0.01% | 5687 |
|
|
2021
Q2 | $16K | Sell |
88
-385
| -81% | -$70K | ﹤0.01% | 5657 |
|
|
2021
Q1 | $94K | Sell |
473
-1,049
| -69% | -$208K | ﹤0.01% | 5174 |
|
|
2020
Q4 | $300K | Buy |
1,522
+217
| +17% | +$42.8K | ﹤0.01% | 4768 |
|
|
2020
Q3 | $232K | Sell |
1,305
-50
| -4% | -$8.89K | ﹤0.01% | 4733 |
|
|
2020
Q2 | $313K | Sell |
1,355
-1,385
| -51% | -$320K | ﹤0.01% | 4505 |
|
|
2020
Q1 | $319K | Buy |
2,740
+511
| +23% | +$59.5K | ﹤0.01% | 4237 |
|
|
2019
Q4 | $425K | Sell |
2,229
-3
| -0.1% | -$572 | ﹤0.01% | 4386 |
|
|
2019
Q3 | $429K | Sell |
2,232
-217
| -9% | -$41.7K | ﹤0.01% | 4359 |
|
|
2019
Q2 | $419K | Buy |
2,449
+830
| +51% | +$142K | ﹤0.01% | 4379 |
|
|
2019
Q1 | $326K | Buy |
1,619
+56
| +4% | +$11.3K | ﹤0.01% | 4515 |
|
|
2018
Q4 | $293K | Buy |
1,563
+819
| +110% | +$154K | ﹤0.01% | 4524 |
|
|
2018
Q3 | $178K | Sell |
744
-1,344
| -64% | -$322K | ﹤0.01% | 4877 |
|
|
2018
Q2 | $552K | Buy |
2,088
+997
| +91% | +$264K | ﹤0.01% | 4278 |
|
|
2018
Q1 | $271K | Buy |
1,091
+174
| +19% | +$43.2K | ﹤0.01% | 4650 |
|
|
2017
Q4 | $124K | Buy |
917
+176
| +24% | +$23.8K | ﹤0.01% | 5006 |
|
|
2017
Q3 | $91K | Sell |
741
-145
| -16% | -$17.8K | ﹤0.01% | 5035 |
|
|
2017
Q2 | $85K | Buy |
886
+258
| +41% | +$24.8K | ﹤0.01% | 4997 |
|
|
2017
Q1 | $117K | Sell |
628
-63
| -9% | -$11.7K | ﹤0.01% | 4900 |
|
|
2016
Q4 | $75K | Buy |
691
+579
| +517% | +$62.8K | ﹤0.01% | 5023 |
|
|
2016
Q3 | $18K | Buy |
112
+20
| +22% | +$3.21K | ﹤0.01% | 5322 |
|
|
2016
Q2 | $11K | Buy |
+92
| New | +$11K | ﹤0.01% | 5363 |
|